Including a subject-paced trial may make the PASAT more acceptable for MS patients

O. Bosnes, O.-P. Dahl, O. Almkvist
  • Acta Neurologica Scandinavica, February 2015, Wiley
  • DOI: 10.1111/ane.12385
The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: Dr Ole Bosnes

In partnership with: